Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings

被引:45
作者
Harper, C. C.
Blanchard, K.
Grossman, D.
Henderson, J. T.
Darney, P. D.
机构
[1] Univ Calif San Francisco, Bixby Ctr Reprod Hlth Res & Policy, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94118 USA
[2] Ibis Reprod Hlth, Cambridge, MA USA
关键词
maternal mortality; misoprostol abortion; medical abortion;
D O I
10.1016/j.ijgo.2007.03.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Over 99% of deaths due to abortion occur in developing countries. Maternal deaths due to abortion are preventable. Increasing the use of misoprostol for elective abortion could have a notable impact on maternal mortality due to abortion. As a test of this hypothesis, this study estimated the reduction in maternal deaths due to abortion in Africa, Asia and Latin America. The estimates were adjusted to changes in assumptions, yielding different possible scenarios of tow and high estimates. This simple modeling exercise demonstrated that increased use of misoprostol, an option for pregnancy termination already available to many women in developing countries, could significantly reduce mortality due to abortion. Empirical testing of the hypothesis with data collected from developing countries could help to inform and improve the use of misoprostol in those settings. (c) 2007 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:66 / 69
页数:4
相关论文
共 32 条
[1]  
[Anonymous], 2004, UNS AB GLOB REG EST
[2]  
[Anonymous], WHO TECHN REP SER
[3]   Medical abortion in the first trimester [J].
Baird, DT .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2002, 16 (02) :221-236
[4]   Risk factors for legal induced abortion-related mortality in the United States [J].
Bartlett, LA ;
Berg, CJ ;
Shulman, HB ;
Zane, SB ;
Green, CA ;
Whitehead, S ;
Atrash, HK .
OBSTETRICS AND GYNECOLOGY, 2004, 103 (04) :729-737
[5]   Misoprostol alone for early medical abortion in a Latin American clinic setting [J].
Billings, DL .
REPRODUCTIVE HEALTH MATTERS, 2004, 12 (24) :57-64
[6]   Misoprostol alone for early abortion: an evaluation of seven potential regimens [J].
Blanchard, K ;
Shochet, T ;
Coyaji, K ;
Ngoc, NTN ;
Winikoff, B .
CONTRACEPTION, 2005, 72 (02) :91-97
[7]   Termination of pregnancies of <6 weeks gestation with a single dose of 800 μg of vaginal misoprostol [J].
Bugalho, A ;
Mocumbi, S ;
Faúndes, A ;
David, E .
CONTRACEPTION, 2000, 61 (01) :47-50
[8]  
Carbonell J L, 1997, Eur J Contracept Reprod Health Care, V2, P181
[9]   Medical abortion in early pregnancy: experience in China [J].
Cheng, Linan .
CONTRACEPTION, 2006, 74 (01) :61-65
[10]   Misoprostol use in obstetrics and gynecology in Brazil, Jamaica, and the United States [J].
Clark, S ;
Blum, J ;
Blanchard, K ;
Galvao, L ;
Fletcher, H ;
Winikoff, B .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2002, 76 (01) :65-74